TERN — Terns Pharmaceuticals Inc · $6.12B cap

Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.

Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.

Use this TERN page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the TERN quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the TERN SEC filings page. Lician reads the product cache first so this HTML stays unique to Terns Pharmaceuticals Inc even when a live quote feed is slow.

Terns Pharmaceuticals Inc latest statements (FY2024)

Latest cached year on this hub. Full TERN income, balance, and cash tables.

  • Revenue$0
  • Net Income-$88.9M
  • Total Assets$363.9M
  • Total Debt$0
  • Free Cash Flow$0

TERN recent filings